Peer review reports
From: Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status
Original Submission |
10 Apr 2015 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Publishing |
21 Aug 2015 |
Editorially accepted |
|
9 Sep 2015 |
Article published |
10.1186/s12885-015-1621-2
|
Learn about peer review